{"id": "IEPA.d11.s27_IEPA.d11.s27.p0", "text": "This suggests that amyloid beta protein activation of phospholipase C may be receptor mediated", "text_with_entity_marker": "This suggests that [E1]amyloid[/E1] beta protein activation of [E2]phospholipase C[/E2] may be receptor mediated", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[19, 26]], "entity_1_idx_in_text_with_entity_marker": [23, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d12.s29_IEPA.d12.s29.p1", "text": "These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway", "text_with_entity_marker": "These results suggest that [E1]APP-S[/E1] secretion and A beta production in NT2N neurons are regulated by the muscarinic/[E2]phospholipase C[/E2] signal transduction pathway", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APP-S", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[113, 128]], "entity_2_idx_in_text_with_entity_marker": [126, 141], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s34_IEPA.d17.s34.p0", "text": "The aim of this study was to investigate the effects of hCG, hCG plus oxytocin and oxytocin on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts", "text_with_entity_marker": "The aim of this study was to investigate the effects of hCG, hCG plus [E1]oxytocin[/E1] and [E2]oxytocin[/E2] on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[70, 78]], "entity_1_idx_in_text_with_entity_marker": [74, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[83, 91]], "entity_2_idx_in_text_with_entity_marker": [96, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s38_IEPA.d17.s38.p0", "text": "The highest dose of hCG plus The highest dose of hCG plus oxytocin provoked accumulation of total [3H]inositol phosphate (p < 0.05) 53% over the basal level on days 21/1 of the estrous cycle", "text_with_entity_marker": "The highest dose of hCG plus The highest dose of hCG plus [E1]oxytocin[/E1] provoked accumulation of total [3H][E2]inositol phosphate[/E2] (p < 0.05) 53% over the basal level on days 21/1 of the estrous cycle", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[58, 66]], "entity_1_idx_in_text_with_entity_marker": [62, 70], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphate", "entity_2_idx": [[102, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 133], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p1", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal [E1]prion protein[/E1] isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal [E2]prion protein[/E2] isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[269, 282]], "entity_2_idx_in_text_with_entity_marker": [282, 295], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p8", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal [E1]prion protein[/E1] isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific [E2]kinase[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "prion protein", "entity_1_idx": [[269, 282]], "entity_1_idx_in_text_with_entity_marker": [273, 286], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[446, 452]], "entity_2_idx_in_text_with_entity_marker": [459, 465], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p9", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a [E1]prion protein[/E1]-specific [E2]kinase[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "prion protein", "entity_1_idx": [[423, 436]], "entity_1_idx_in_text_with_entity_marker": [427, 440], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[446, 452]], "entity_2_idx_in_text_with_entity_marker": [459, 465], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p0", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated [E1]PrPsc[/E1] aggregates to freshly synthesized [E2]PrPc[/E2], transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PrPsc", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PrPc", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p5", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a [E1]prion protein[/E1]-specific [E2]protein kinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "prion protein", "entity_1_idx": [[203, 216]], "entity_1_idx_in_text_with_entity_marker": [207, 220], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p1", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The [E1]oxytocin[/E1] antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on [E2]oxytocin[/E2]-induced insulin secretion was difficult to evaluate", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s72_IEPA.d33.s72.p0", "text": "OBJECTIVE: In order to elucidate the roles of inositol trisphosphate (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of IP3 induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition", "text_with_entity_marker": "OBJECTIVE: In order to elucidate the roles of [E1]inositol trisphosphate[/E1] (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of [E2]IP3[/E2] induced by OT and the OT receptor levels were determined in rabbit myometria before and after parturition", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol trisphosphate", "entity_1_idx": [[46, 68]], "entity_1_idx_in_text_with_entity_marker": [50, 72], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[147, 150]], "entity_2_idx_in_text_with_entity_marker": [160, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s84_IEPA.d34.s84.p0", "text": "In obese (db/db) animals, brown fat was composed mainly of small unilocular, UCP-positive adipocytes (mean diameter: 40.08 microns), which were also leptin-positive", "text_with_entity_marker": "In obese (db/db) animals, brown fat was composed mainly of small unilocular, [E1]UCP[/E1]-positive adipocytes (mean diameter: 40.08 microns), which were also [E2]leptin[/E2]-positive", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s96_IEPA.d40.s96.p0", "text": "Roles of GTP and phospholipase C in the potentiation of Ca(2+)-induced insulin secretion by glucose in rat pancreatic islets", "text_with_entity_marker": "Roles of GTP and [E1]phospholipase C[/E1] in the potentiation of Ca(2+)-induced [E2]insulin[/E2] secretion by glucose in rat pancreatic islets", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[17, 32]], "entity_1_idx_in_text_with_entity_marker": [21, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[71, 78]], "entity_2_idx_in_text_with_entity_marker": [84, 91], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s99_IEPA.d40.s99.p3", "text": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "text_with_entity_marker": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that [E1]PLC[/E1] activation can clearly be dissociated from [E2]insulin[/E2] secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[151, 154]], "entity_1_idx_in_text_with_entity_marker": [155, 158], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s99_IEPA.d40.s99.p4", "text": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that PLC activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced insulin secretion", "text_with_entity_marker": "These data indicate that an adequate level of GTP is critical for glucose's potentiation of Ca(2+)-induced insulin secretion in primed islets but that [E1]PLC[/E1] activation can clearly be dissociated from insulin secretion and therefore cannot be the major cause of glucose's augmentation of Ca(2+)-induced [E2]insulin[/E2] secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[151, 154]], "entity_1_idx_in_text_with_entity_marker": [155, 158], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[300, 307]], "entity_2_idx_in_text_with_entity_marker": [313, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s110_IEPA.d43.s110.p0", "text": "Leptin overexpression increased UCP-2 mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats", "text_with_entity_marker": "[E1]Leptin[/E1] overexpression increased [E2]UCP-2[/E2] mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s116_IEPA.d46.s116.p0", "text": "This phospholipase C stimulation by amyloid beta protein appeared to be pertussis toxin sensitive", "text_with_entity_marker": "This [E1]phospholipase C[/E1] stimulation by [E2]amyloid[/E2] beta protein appeared to be pertussis toxin sensitive", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[5, 20]], "entity_1_idx_in_text_with_entity_marker": [9, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[36, 43]], "entity_2_idx_in_text_with_entity_marker": [49, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d47.s120_IEPA.d47.s120.p0", "text": "Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep", "text_with_entity_marker": "Effects of [E1]oxytocin[/E1], arginine-vasopressin and lysine-vasopressin on [E2]insulin[/E2] and glucagon secretion in sheep", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s129_IEPA.d50.s129.p1", "text": "A specific enhancement in PLC-mediated insulin secretion is the earliest reported developmental alteration in insulin secretion from islets of ob/ob mice, and thus a logical target for leptin action", "text_with_entity_marker": "A specific enhancement in [E1]PLC[/E1]-mediated insulin secretion is the earliest reported developmental alteration in [E2]insulin[/E2] secretion from islets of ob/ob mice, and thus a logical target for leptin action", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[110, 117]], "entity_2_idx_in_text_with_entity_marker": [123, 130], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s147_IEPA.d57.s147.p0", "text": "Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "text_with_entity_marker": "Despite the low levels of [E1]insulin[/E1]-induced [E2]PLC[/E2] activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s152_IEPA.d58.s152.p1", "text": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH", "text_with_entity_marker": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by [E1]PKC[/E1] in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with [E2]PKC[/E2] translocation and the release of ACTH", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC", "entity_1_idx": [[88, 91]], "entity_1_idx_in_text_with_entity_marker": [92, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[304, 307]], "entity_2_idx_in_text_with_entity_marker": [317, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s152_IEPA.d58.s152.p2", "text": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether AVP might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with PKC translocation and the release of ACTH", "text_with_entity_marker": "Since the MARCKS protein has been implicated in neurosecretion and is phosphorylated by PKC in synaptosomes, studies were carried out to determine whether [E1]AVP[/E1] might cause MARCKS phosphorylation in the ovine anterior pituitary, and to determine whether this phenomenon might be temporally correlated with [E2]PKC[/E2] translocation and the release of ACTH", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[155, 158]], "entity_1_idx_in_text_with_entity_marker": [159, 162], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[304, 307]], "entity_2_idx_in_text_with_entity_marker": [317, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s153_IEPA.d58.s153.p2", "text": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "text_with_entity_marker": "We conclude that: (1) [E1]AVP[/E1] causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of [E2]PKC[/E2] activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[329, 332]], "entity_2_idx_in_text_with_entity_marker": [342, 345], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d66.s166_IEPA.d66.s166.p1", "text": "However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "text_with_entity_marker": "However, the [E1]AVP[/E1]-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was [E2]PKC[/E2] independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[113, 116]], "entity_2_idx_in_text_with_entity_marker": [126, 129], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s167_IEPA.d67.s167.p1", "text": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin", "text_with_entity_marker": "Association of the insulin receptor with [E1]phospholipase C-gamma[/E1] (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C-gamma", "entity_1_idx": [[41, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 66], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s167_IEPA.d67.s167.p2", "text": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin", "text_with_entity_marker": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for [E1]PLCgamma[/E1] in metabolic signaling by [E2]insulin[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLCgamma", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p0", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of [E2]PLC[/E2], U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[116, 119]], "entity_2_idx_in_text_with_entity_marker": [129, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d76.s183_IEPA.d76.s183.p0", "text": "In order to establish whether melatonin alters basal and/or stimulated oxytocin secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of insulin (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)", "text_with_entity_marker": "In order to establish whether melatonin alters basal and/or stimulated [E1]oxytocin[/E1] secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of [E2]insulin[/E2] (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[71, 79]], "entity_1_idx_in_text_with_entity_marker": [75, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s187_IEPA.d78.s187.p0", "text": "To assess the possible involvement of PKC in AVP and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested", "text_with_entity_marker": "To assess the possible involvement of [E1]PKC[/E1] in [E2]AVP[/E2] and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s191_IEPA.d80.s191.p0", "text": "A single i.c.v. injection of leptin decreased cumulative food intake and body weight gain, and increased UCP-1 mRNA expression during 3 h at the onset of the dark phase", "text_with_entity_marker": "A single i.c.v. injection of [E1]leptin[/E1] decreased cumulative food intake and body weight gain, and increased [E2]UCP-1[/E2] mRNA expression during 3 h at the onset of the dark phase", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d82.s195_IEPA.d82.s195.p0", "text": "Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein", "text_with_entity_marker": "Neural site of [E1]leptin[/E1] influence on neuropeptide Y signaling pathways altering feeding and [E2]uncoupling protein[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[15, 21]], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[90, 108]], "entity_2_idx_in_text_with_entity_marker": [103, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s199_IEPA.d84.s199.p1", "text": "Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics", "text_with_entity_marker": "Effect of residual endogenous [E1]insulin[/E1] secretion on the abnormal oxytocin response to hypoglycaemia in [E2]insulin[/E2]-dependent diabetics", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[30, 37]], "entity_1_idx_in_text_with_entity_marker": [34, 41], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s201_IEPA.d84.s201.p0", "text": "DESIGN: Case-control study: the OT response to insulin-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion", "text_with_entity_marker": "DESIGN: Case-control study: the [E1]OT[/E1] response to [E2]insulin[/E2]-induced hypoglycaemia was measured in normal and diabetic patients with or without residual endogenous insulin secretion", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[32, 34]], "entity_1_idx_in_text_with_entity_marker": [36, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[47, 54]], "entity_2_idx_in_text_with_entity_marker": [60, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d86.s205_IEPA.d86.s205.p0", "text": "These observations suggest that bradykinin, like oxytocin, activates phospholipase C which generates IP3 with a subsequent release of Ca2+ from intracellular stores followed by store-operated Ca2+ influx", "text_with_entity_marker": "These observations suggest that bradykinin, like [E1]oxytocin[/E1], activates phospholipase C which generates [E2]IP3[/E2] with a subsequent release of Ca2+ from intracellular stores followed by store-operated Ca2+ influx", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[49, 57]], "entity_1_idx_in_text_with_entity_marker": [53, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[101, 104]], "entity_2_idx_in_text_with_entity_marker": [114, 117], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s211_IEPA.d89.s211.p2", "text": "Leptin increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased UCP2 mRNA levels twofold in EWAT", "text_with_entity_marker": "[E1]Leptin[/E1] increased LPL mRNA by 80%, UCP1 mRNA twofold, and UCP3 mRNA levels by 62% in BAT, and increased [E2]UCP2[/E2] mRNA levels twofold in EWAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s220_IEPA.d91.s220.p0", "text": "AIM: To study the mechanisms underlying oxytocin (Oxy)-induced insulin release", "text_with_entity_marker": "AIM: To study the mechanisms underlying [E1]oxytocin[/E1] (Oxy)-induced [E2]insulin[/E2] release", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d93.s226_IEPA.d93.s226.p2", "text": "Further investigation suggested that activation of protein kinase C (PKC), which is part of the AVP-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release", "text_with_entity_marker": "Further investigation suggested that activation of protein kinase C (PKC), which is part of the [E1]AVP[/E1]-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for [E2]AVP[/E2]-induced ACTH release", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[252, 255]], "entity_2_idx_in_text_with_entity_marker": [265, 268], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s232_IEPA.d96.s232.p2", "text": "Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%)", "text_with_entity_marker": "Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in [E1]UCP-2[/E1] mRNA in WAT (47-52%) and [E2]UCP-3[/E2] mRNA in SM (33-37%)", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s237_IEPA.d99.s237.p0", "text": "Enhanced phosphoinositide hydrolysis via overexpression of phospholipase C beta1 or delta1 inhibits stimulus-induced insulin release in insulinoma MIN6 cells.", "text_with_entity_marker": "Enhanced phosphoinositide hydrolysis via overexpression of [E1]phospholipase C[/E1] beta1 or delta1 inhibits stimulus-induced [E2]insulin[/E2] release in insulinoma MIN6 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[59, 74]], "entity_1_idx_in_text_with_entity_marker": [63, 78], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[117, 124]], "entity_2_idx_in_text_with_entity_marker": [130, 137], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p2", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific [E1]phospholipase Cbeta1[/E1] (PLCbeta1) or [E2]PLCdelta1[/E2] was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase Cbeta1", "entity_1_idx": [[109, 129]], "entity_1_idx_in_text_with_entity_marker": [113, 133], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCdelta1", "entity_2_idx": [[144, 153]], "entity_2_idx_in_text_with_entity_marker": [157, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s254_IEPA.d108.s254.p0", "text": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with oxytocin or saline, plasma levels of insulin and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "text_with_entity_marker": "When the alpha2-adrenoreceptor agonist clonidine (2.5 microgram/kg intracerebroventricularly) was administered 3 days after the 5-day treatment period with [E1]oxytocin[/E1] or saline, plasma levels of [E2]insulin[/E2] and CCK increased significantly (p < 0.05) in the oxytocin-treated rats, when compared to saline-treated controls receiving clonidine only", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s257_IEPA.d109.s257.p0", "text": "In this study, we examined the effects of fasting for 2 days and exogenous s.c. leptin, 200 microg every 8 h for 2 days, on the regulation of uncoupling protein (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle", "text_with_entity_marker": "In this study, we examined the effects of fasting for 2 days and exogenous s.c. [E1]leptin[/E1], 200 microg every 8 h for 2 days, on the regulation of [E2]uncoupling protein[/E2] (UCP) subtypes in brown adipose tissue (BAT) and gastrocnemius muscle", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[80, 86]], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[142, 160]], "entity_2_idx_in_text_with_entity_marker": [155, 173], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p1", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without [E1]leptin[/E1] administration, did not affect BAT UCP-2 mRNA; however, [E2]leptin[/E2] administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[88, 94]], "entity_2_idx_in_text_with_entity_marker": [101, 107], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p5", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, [E1]leptin[/E1] administration to ad libitum fed rats significantly increased BAT [E2]UCP-2[/E2] mRNA, to 138% of control", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[88, 94]], "entity_1_idx_in_text_with_entity_marker": [92, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d112.s270_IEPA.d112.s270.p0", "text": "Analyses of hormone regulation of expression of mRNA for the aleurone RNase revealed that, like the pattern for alpha-amylase, mRNA levels increased in the presence of gibberellic acid, and its antagonist abscisic acid prevented this effect", "text_with_entity_marker": "Analyses of hormone regulation of expression of mRNA for the aleurone RNase revealed that, like the pattern for [E1]alpha-amylase[/E1], mRNA levels increased in the presence of [E2]gibberellic acid[/E2], and its antagonist abscisic acid prevented this effect", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[112, 125]], "entity_1_idx_in_text_with_entity_marker": [116, 129], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "gibberellic acid", "entity_2_idx": [[168, 184]], "entity_2_idx_in_text_with_entity_marker": [181, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p2", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether [E1]UCP-2[/E1] does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the [E2]UCP-2[/E2] gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d114.s275_IEPA.d114.s275.p4", "text": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in leptin-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the UCP-2 gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "text_with_entity_marker": "To determine whether UCP-2 does, in fact, have uncoupling activity and, if so, whether such activity would favorably influence the abnormalities in [E1]leptin[/E1]-unresponsive UCP-2-underexpressing islets of diabetic ZDF rats, we transferred the [E2]UCP-2[/E2] gene to the islets of diabetic ZDF rats and lean (+/+) ZDF control rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d117.s285_IEPA.d117.s285.p4", "text": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "text_with_entity_marker": "The second class of mutant, gse (GA sensitivity), differed principally in [E1]GA[/E1] sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and [E2]alpha-amylase[/E2] production by aleurone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[74, 76]], "entity_1_idx_in_text_with_entity_marker": [78, 80], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p5", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E2]UCP3[/E2] in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d124.s297_IEPA.d124.s297.p2", "text": "By comparison with the promoters of alpha-amylase genes, which are also induced by GA, we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a GA response complex", "text_with_entity_marker": "By comparison with the promoters of alpha-amylase genes, which are also induced by [E1]GA[/E1], we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a [E2]GA[/E2] response complex", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[83, 85]], "entity_1_idx_in_text_with_entity_marker": [87, 89], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[178, 180]], "entity_2_idx_in_text_with_entity_marker": [191, 193], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p1", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine [E1]UCP2[/E1] and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT [E2]leptin[/E2] mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[153, 159]], "entity_2_idx_in_text_with_entity_marker": [166, 172], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p1", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that [E1]UCP[/E1] gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and [E2]UCP3[/E2] mRNA may be due to increased leptin levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p2", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that [E1]UCP[/E1] gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased [E2]leptin[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[172, 178]], "entity_2_idx_in_text_with_entity_marker": [185, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d127.s301_IEPA.d127.s301.p1", "text": "PI-PLC treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and Abeta42 in the medium but had no effect on sAPPalpha", "text_with_entity_marker": "[E1]PI-PLC[/E1] treatment of fetal guinea pig brain cultures substantially reduced the amount of Abeta40 and [E2]Abeta42[/E2] in the medium but had no effect on sAPPalpha", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PI-PLC", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Abeta42", "entity_2_idx": [[100, 107]], "entity_2_idx_in_text_with_entity_marker": [113, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s307_IEPA.d129.s307.p0", "text": "Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats", "text_with_entity_marker": "Sympathetic inhibition, [E1]leptin[/E1], and [E2]uncoupling protein[/E2] subtype expression in normal fasting rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[36, 54]], "entity_2_idx_in_text_with_entity_marker": [49, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d129.s311_IEPA.d129.s311.p0", "text": "However, the in vivo modulation of leptin and UCPs appears complex and, beyond a causal effect of SNA per se, may depend on concurrent changes in plasma insulin, glucose, and circulatory hemodynamics", "text_with_entity_marker": "However, the in vivo modulation of [E1]leptin[/E1] and [E2]UCPs[/E2] appears complex and, beyond a causal effect of SNA per se, may depend on concurrent changes in plasma insulin, glucose, and circulatory hemodynamics", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[35, 41]], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCPs", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p0", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal [E2]PIP2-PLC[/E2] activity and cytosolic PI-PLC and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s315_IEPA.d130.s315.p0", "text": "The aggregated form of A beta 25-35 significantly inhibited PIP2-PLC only in the presence of endogenous CaCl2", "text_with_entity_marker": "The aggregated form of [E1]A beta[/E1] 25-35 significantly inhibited [E2]PIP2-PLC[/E2] only in the presence of endogenous CaCl2", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A beta", "entity_1_idx": [[23, 29]], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d131.s318_IEPA.d131.s318.p0", "text": "These results indicate that PKC is upstream of the phosphorylation, a motion which is supported by the fact that the AVP-stimulated phosphorylation was downregulated by phorbol esters", "text_with_entity_marker": "These results indicate that [E1]PKC[/E1] is upstream of the phosphorylation, a motion which is supported by the fact that the [E2]AVP[/E2]-stimulated phosphorylation was downregulated by phorbol esters", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s319_IEPA.d132.s319.p0", "text": "The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of gibberellin-inducible alpha-amylase induction in embryoless barley half-seeds", "text_with_entity_marker": "The effects of the fluorinated analogues were evaluated on inhibition of cress seed germination and inhibition of [E1]gibberellin[/E1]-inducible [E2]alpha-amylase[/E2] induction in embryoless barley half-seeds", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[114, 125]], "entity_1_idx_in_text_with_entity_marker": [118, 129], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d132.s320_IEPA.d132.s320.p2", "text": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible alpha-amylase induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of alpha-amylase production", "text_with_entity_marker": "(2E, 4E)-2-Fluoro-5-(1'-hydroxy-2',6', 6'-trimethyl-2'-cyclohexen-1'-yl)-3-methyl-2,4-pentadienoic acid (5b) showed potent inhibitory activity at the same level as ABA in the cress seed germination test, and 5b also inhibited gibberellin-inducible [E1]alpha-amylase[/E1] induction at 4 x 10(-)(6), 3 times the concentration of ABA (1 x 10(-)(6)) for 50% inhibition of [E2]alpha-amylase[/E2] production", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-amylase", "entity_1_idx": [[248, 261]], "entity_1_idx_in_text_with_entity_marker": [252, 265], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[359, 372]], "entity_2_idx_in_text_with_entity_marker": [372, 385], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d136.s324_IEPA.d136.s324.p0", "text": "The etiology for diabetes mellitus in PWS may be related to the morbid obesity and consequent insulin resistance, because a decrease of oxytocin neurons and leptin resistance in PWS may cause hyperphagia, inducing obesity", "text_with_entity_marker": "The etiology for diabetes mellitus in PWS may be related to the morbid obesity and consequent [E1]insulin[/E1] resistance, because a decrease of [E2]oxytocin[/E2] neurons and leptin resistance in PWS may cause hyperphagia, inducing obesity", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s332_IEPA.d138.s332.p1", "text": "The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase", "text_with_entity_marker": "The data suggest that mammalian [E1]insulin[/E1]-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the [E2]insulin[/E2] signal from the respective receptor systems to glycogen synthase and phosphorylase", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s333_IEPA.d139.s333.p0", "text": "Leptin and UCP (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle", "text_with_entity_marker": "[E1]Leptin[/E1] and [E2]UCP[/E2] (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[11, 14]], "entity_2_idx_in_text_with_entity_marker": [24, 27], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p1", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and [E1]UCP2[/E1] expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma [E2]leptin[/E2] and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[422, 428]], "entity_2_idx_in_text_with_entity_marker": [435, 441], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s353_IEPA.d146.s353.p0", "text": "The PKC inhibitors Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or AVP", "text_with_entity_marker": "The [E1]PKC inhibitors[/E1] Ro-31-8220 (1 microM) and calphostin C (250 nM) completely blocked the stimulation of Ca2+ spiking by either PMA or [E2]AVP[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC inhibitors", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d146.s354_IEPA.d146.s354.p0", "text": "Time-dependent redistribution of PKC-alpha, -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM AVP", "text_with_entity_marker": "Time-dependent redistribution of [E1]PKC-alpha[/E1], -delta and -epsilon isoforms between the membrane and cytosolic fractions occurred in response to 100 pM [E2]AVP[/E2]", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PKC-alpha", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s359_IEPA.d148.s359.p0", "text": "In vivo effects of CGP-12177 on the expression of leptin and uncoupling protein genes in mouse brown and white adipose tissues", "text_with_entity_marker": "In vivo effects of CGP-12177 on the expression of [E1]leptin[/E1] and [E2]uncoupling protein[/E2] genes in mouse brown and white adipose tissues", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[50, 56]], "entity_1_idx_in_text_with_entity_marker": [54, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[61, 79]], "entity_2_idx_in_text_with_entity_marker": [74, 92], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s374_IEPA.d157.s374.p0", "text": "We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the gibberellin-induced expression of alpha-amylase in the aleurone layer and the scutellar tissues", "text_with_entity_marker": "We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] in the aleurone layer and the scutellar tissues", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[157, 168]], "entity_1_idx_in_text_with_entity_marker": [161, 172], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[191, 204]], "entity_2_idx_in_text_with_entity_marker": [204, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s380_IEPA.d158.s380.p0", "text": "However, NPY inhibited and leptin stimulated intake if the solution was infused intraorally", "text_with_entity_marker": "However, [E1]NPY[/E1] inhibited and [E2]leptin[/E2] stimulated intake if the solution was infused intraorally", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[27, 33]], "entity_2_idx_in_text_with_entity_marker": [40, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d162.s390_IEPA.d162.s390.p1", "text": "We previously reported that adiposity and serum leptin levels increase with age in male F-344xBN rats and that when physiological levels of serum leptin are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic neuropeptide Y (NPY) mRNA in young rats, but there are no changes in older rats", "text_with_entity_marker": "We previously reported that adiposity and serum [E1]leptin[/E1] levels increase with age in male F-344xBN rats and that when physiological levels of serum leptin are manipulated by fasting, there is a corresponding reciprocal change in hypothalamic [E2]neuropeptide Y[/E2] (NPY) mRNA in young rats, but there are no changes in older rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[240, 254]], "entity_2_idx_in_text_with_entity_marker": [253, 267], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d165.s397_IEPA.d165.s397.p0", "text": "Interactions between leptin and NPY affecting lipid mobilization in adipose tissue", "text_with_entity_marker": "Interactions between [E1]leptin[/E1] and [E2]NPY[/E2] affecting lipid mobilization in adipose tissue", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[21, 27]], "entity_1_idx_in_text_with_entity_marker": [25, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d165.s399_IEPA.d165.s399.p0", "text": "The lipolytic rate was assessed through glycerol release after incubation with leptin and NPY at concentrations ranging from 10(-6) to 10(-12) M in isolated adipocytes obtained from female rats", "text_with_entity_marker": "The lipolytic rate was assessed through glycerol release after incubation with [E1]leptin[/E1] and [E2]NPY[/E2] at concentrations ranging from 10(-6) to 10(-12) M in isolated adipocytes obtained from female rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[79, 85]], "entity_1_idx_in_text_with_entity_marker": [83, 89], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p1", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking [E1]leptin[/E1]-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of [E2]leptin[/E2] prevented such a decrease in UCP-3", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[86, 92]], "entity_1_idx_in_text_with_entity_marker": [90, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[223, 229]], "entity_2_idx_in_text_with_entity_marker": [236, 242], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p3", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle [E1]uncoupling protein-3[/E1] (UCP-3), whereas ICV infusion of [E2]leptin[/E2] prevented such a decrease in UCP-3", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling protein-3", "entity_1_idx": [[169, 189]], "entity_1_idx_in_text_with_entity_marker": [173, 193], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[223, 229]], "entity_2_idx_in_text_with_entity_marker": [236, 242], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s420_IEPA.d173.s420.p0", "text": "In contrast, secretion of N1 remains unaffected by the inactive PDBu analog alphaPDD and by the protein kinase A effectors dibutyryl cAMP and forskolin", "text_with_entity_marker": "In contrast, secretion of [E1]N1[/E1] remains unaffected by the inactive PDBu analog alphaPDD and by the [E2]protein kinase A[/E2] effectors dibutyryl cAMP and forskolin", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase A", "entity_2_idx": [[96, 112]], "entity_2_idx_in_text_with_entity_marker": [109, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s421_IEPA.d173.s421.p0", "text": "Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons", "text_with_entity_marker": "Overall, our data indicate that the normal processing of [E1]PrP(c)[/E1] is up-regulated by [E2]protein kinase C[/E2] but not protein kinase A in human cells and murine neurons", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PrP(c)", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[83, 99]], "entity_2_idx_in_text_with_entity_marker": [96, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d173.s421_IEPA.d173.s421.p1", "text": "Overall, our data indicate that the normal processing of PrP(c) is up-regulated by protein kinase C but not protein kinase A in human cells and murine neurons", "text_with_entity_marker": "Overall, our data indicate that the normal processing of [E1]PrP(c)[/E1] is up-regulated by protein kinase C but not [E2]protein kinase A[/E2] in human cells and murine neurons", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PrP(c)", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase A", "entity_2_idx": [[108, 124]], "entity_2_idx_in_text_with_entity_marker": [121, 137], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s434_IEPA.d180.s434.p0", "text": "Leptin increases the expression of uncoupling proteins (UCP-1, -2, -3) and thus energy dissipation", "text_with_entity_marker": "[E1]Leptin[/E1] increases the expression of [E2]uncoupling proteins[/E2] (UCP-1, -2, -3) and thus energy dissipation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[35, 54]], "entity_2_idx_in_text_with_entity_marker": [48, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d194.s465_IEPA.d194.s465.p0", "text": "Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase Cgamma and protein kinase Calpha signalling cascade.", "text_with_entity_marker": "[E1]Insulin[/E1]-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the [E2]phospholipase Cgamma[/E2] and protein kinase Calpha signalling cascade.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma", "entity_2_idx": [[115, 135]], "entity_2_idx_in_text_with_entity_marker": [128, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d194.s468_IEPA.d194.s468.p0", "text": "In summary, we demonstrate that insulin treatment results in activation of both PLD1 and PLD2 in appropriate cell types when the appropriate upstream intermediate signalling components, i.e. PKCalpha and PLCgamma, are expressed at sufficient levels.", "text_with_entity_marker": "In summary, we demonstrate that [E1]insulin[/E1] treatment results in activation of both PLD1 and PLD2 in appropriate cell types when the appropriate upstream intermediate signalling components, i.e. PKCalpha and [E2]PLCgamma[/E2], are expressed at sufficient levels.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
